Company: TVRD
Filing Date: 2025-04-15
Form Type: 8-K
Source: 0001104659-25-035121
Chunk: 9

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-04-15
Form: 8-K
Item: Item 9.01
Chunk 9
---
Item 9.01. Financial Statements and Exhibits.

(a) Financial Statements of Business Acquired

The audited consolidated financial statements of Cara as of and for
the years ended December 31, 2023 and 2024 and the related notes are included in Cara’s Annual Report on Form 10-K, filed
with the SEC on March 11, 2025, and are incorporated herein by reference.

The audited financial statements of Tvardi as of and for the years
ended December 31, 2023 and 2024 are filed herewith as Exhibit 99.3 and are incorporated herein by reference.

(b) Pro Forma Financial Information

The unaudited pro forma condensed combined financial information of
the Company as of and for the year ended December 31, 2024 is set forth in Exhibit 99.5 hereto and is incorporated herein by
reference.

  Exhibit No.      Description                                                                                                                                                                                           
  3.1*             Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Cara Therapeutics, Inc., dated April 15, 2025 (Stock Split Amendment).                                           
  3.2*             Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Cara Therapeutics, Inc., dated April 15, 2025 (Authorized Shares Amendment).                                     
  3.3*             Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Cara Therapeutics, Inc., dated April 15, 2025 (Name Change Amendment).                                           
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  2.1‡**           Agreement and Plan of Merger and Reorganization, dated as of December 17, 2024, by and among Cara Therapeutics, Inc., CT Convergence Merger Sub, Inc. and Tvardi Therapeutics, Inc. (incorporated...  
  2.2†**           Asset Purchase Agreement, dated December 17, 2024, by and among Cara Therapeutics, Inc., Cara Royalty Sub, LLC and Vifor Fresenius Medical Care Renal Pharma, Ltd. (incorporated by reference fro...  
  10.1#*           Form of Indemnification Agreement between the Company and each of its directors and executive officers.                                                                                               
  10.2*